Teva Pharmaceutical Industries | TEVA - Operating Expenses

Stock Price
10,090.00
Daily Change
-220.00 -2.13%
Monthly
6.78%
Yearly
66.67%
Q2 Forecast
10,239.83

Teva Pharmaceutical Industries reported $3.22B in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
Aspen Pharmacare ZAR 13.32B 5.36B Dec/2025
Cipla INR 60.98B 1.06B Dec/2025
Dr.Reddys Laboratories INR 74.58B 977M Mar/2026
Guangzhou Baiy CNY 21.02B 4.38B Mar/2026
Jiangsu Hengrui CNY 5.52B 604.29M Mar/2026
Kalbe Farma IDR 8.06T 883.47B Sep/2025
Richter Gedeon HUF 151.11B 20.72B Sep/2025
Sh Fosun Pharma CNY 9.18B 2.12B Mar/2026
Sun Pharmaceuticals INR 111.11B 6.97B Sep/2025
Teva Pharmaceutical Industries USD 3.22B 1000M Mar/2026